Table 1:
Racial Discrepancies in Response to Topical Therapies
| AD Patients | Non-AD Patients | ||||
|---|---|---|---|---|---|
| Drug | Treated IOP (mm Hg) | Untreated/Baseline IOP (mm Hg) | Treated IOP (mm Hg) | Untreated/Baseline IOP (mm Hg) | |
| Kass et al, 20023 | Variety | 19.3±2.3 | 23.9±3.2 | 19.3±2.1 | 23.9±2.8 |
| Sommer et al, 199119 | Variety | 20 (exact not provided) | 21.48 ±6.46 | 18.69±3.23 | 24.15±5.23 |
| Netland et al, 200120 | Travoprost (0.004% and 0.0015%), latanoprost 0.005%, and timolol 0.5% | Travoprost 0.004% 8 AM: 18.8 10 AM: 16.7 4 PM: 16.6 Travoprost 0.0015% 8 AM: 19.4 10 AM: 18.8 4 PM: 17.8 Latanoprost 8 AM: 19.7 10 AM: 18.3 4 PM: 18.3 Timolol 8 AM: 22.3 10 AM: 21.0 4 PM: 20.9 |
Travoprost 0.004% 8 AM: 26.8 10 AM: 25.0 4 PM: 24.0 Travoprost 0.0015% 8 AM: 26.1 10 AM: 25.0 4 PM: 24.3 Latanoprost 8 AM: 27.6 10 AM: 25.9 4 PM: 25.2 Timolol 8 AM: 27.2 10 AM: 25.4 4 PM: 24.8 |
Travoprost 0.004% 8 AM: 20.0 10 AM: 18.6 4 PM: 18.4 Travoprost 0.0015% 8 AM: 19.4 10 AM: 18.2 4 PM: 18.2 Latanoprost 8 AM: 19.3 10 AM: 18.0 4 PM: 18.6 Timolol 8 AM: 20.3 10 AM: 19.6 4 PM: 19.6 |
Travoprost 0.004% 8 AM: 26.8 10 AM: 25.2 4 PM: 24.7 Travoprost 0.0015% 8 AM: 26.4 10 AM: 24.7 4 PM: 24.1 Latanoprost 8 AM: 26.6 10 AM: 25.0 4 PM: 24.9 Timolol 8 AM: 26.9 10 AM: 25.4 4 PM: 24.6 |
| Netland et al, 200321 (Pooled data) |
Travoprost 0.004%, latanoprost 0.005%, and timolol 0.5% | Travoprost 8 AM: 18.9 10 AM: 16.8 4 PM: 16.7 |
Travoprost 8 AM: 27.0 10 AM: 25.2 4 PM: 24.3 |
Travoprost 8 AM: 20.2 10 AM: 18.9 4 PM: 18.6 |
Travoprost 8 AM: 27.0 10 AM: 25.4 4 PM: 24.9 |
| Kitnarong et al, 200424 | Latanoprost 0.005% and timolol 0.5% | Timolol 8 AM: 19.2±6.3 10 AM: 17.1±3.7 Latanoprost 8 AM: 16.1±3.7 10 AM: 15.8±3.1 |
Timolol 8 AM: 24.8±7.2 10 AM: 24.2±7.6 Latanoprost 8 AM: 23.4±6.8 10 AM: 25.8±6.1 |
Timolol 8 AM: 17.1±3.3 10 AM: 16.2±4.5 Latanoprost 8 AM: 17.5±3.5 10 AM: 16.7±2.8 |
Timolol 8 AM: 21.7±3.4 10 AM: 21.9±2.6 Latanoprost 8 AM: 22.7±2.2 10 AM: 22.6±3.1 |
| Mansberger et al, 200725 | Nonselective β-adrenergic antagonists, prostaglandin analogues | β-adrenergic antagonists: 19.6±2.8 Prostaglandins: 17.5±3.8 |
β-adrenergic antagonists: 25.8±3.0 Prostaglandins: 25.3±3.9 |
β-adrenergic antagonists: 19.6±3.0 Prostaglandins: 18.3±3.5 |
β-adrenergic antagonists: 26.0±2.8 Prostaglandins: 24.5±3.4 |
| Birt et al, 201026 (Treated: 24-week data) (AD patients a portion of Other (18/33)) |
Bimatoprost, travoprost, and latanoprost | Bimatoprost: 17.0±14.7 Travoprost: 18.6±1.9 Latanoprost: 19.0±2.3 |
Bimatoprost: 25.9±2.5 Travoprost: 29.2±4.6 Latanoprost: 27.2±3.4 |
Bimatoprost: 18.7±1.9 Travoprost: 18.3±4.6 Latanoprost: 17.0±3.8 |
Bimatoprost: 28.3±2.8 Travoprost: 27.8±3.3 Latanoprost: 29.0±3.7 |
African descent (AD), Intraocular pressure (IOP)